CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $53,000 | -8.6% | 24,367 | +33.3% | 0.00% | -20.0% |
| Q1 2022 | $58,000 | -27.5% | 18,275 | -4.4% | 0.01% | -28.6% |
| Q4 2021 | $80,000 | -55.8% | 19,114 | -14.3% | 0.01% | -68.2% |
| Q3 2021 | $181,000 | +19.9% | 22,312 | +11.4% | 0.02% | -4.3% |
| Q2 2021 | $151,000 | +3.4% | 20,031 | +19.2% | 0.02% | -28.1% |
| Q1 2021 | $146,000 | – | 16,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |